Updated:
RHO Capital Partners
Since 1981, Rho has been investing in innovation at all stages of growth. The firm partners with ambitious inventors, entrepreneurs, and operators to create...
RHO Capital Partners
Since 1981, Rho has been investing in innovation at all stages of growth. The firm partners with ambitious inventors, entrepreneurs, and operators to create market defining companies. Rho is a seasoned investor that has backed more than 300 companies through multiple cycles and focuses on partnering with exceptional entrepreneurs in emerging waves of disruption.
General information
Firm type
Private Equity
Year founded
1981
Location
Region
North America
Country
United States
City
New York
Corporate office
Carnegie Hall Tower, 152 West 57th Street, New York, NY 10019, United States
Principals
Joshua Ruch
Co-Founder & Managing Partner
Habib Kairouz
Managing Partner
Mark Leschly
Managing Partner
Dan Ruch
Partner
George Altirs
Investor
Jeff Grammer
Partner
Peter E. Kalkanis
CFO
Roger Chabra
Partner
Sean Brownlee
Partner
Sector focus
Frequently asked questions
Who runs investment decisions at Rho Capital Partners?
Managing Partners Joshua Ruch, Habib Kairouz, and Mark Leschly lead the investment committee. Partners Dan Ruch, Jeff Grammer, Roger Chabra, and Sean Brownlee share senior deal-execution responsibility, while CFO Peter E. Kalkanis oversees the firm's financial operations. George Altirs participates as a named investor within the partnership.
How does Rho source proprietary deal flow?
Rho sources through founder relationships built over four decades, with a stated preference for contrarian ideas that fall outside conventional sector or stage mandates. The firm publicly rejects herd-driven dealflow and describes its origination as coming from serial entrepreneurs it has backed before, graduate-student teams, and corporate-spinout executives.
Does Rho participate in fund commitments or only direct deals?
Rho makes direct investments across venture, growth, buyout, and recapitalization transactions. The firm's public materials emphasize direct co-investment with founders and other investors rather than a primary fund-of-funds allocation strategy, though the partnership syndicates routinely alongside external GPs.
What investment stages does Rho typically target?
Rho deliberately avoids stage specialization. Its mandate spans seed, early-stage venture, late-stage expansion, growth equity, buyouts, and recapitalizations. The partnership describes this boundary-free approach as core to its contrarian philosophy, allowing capital to be deployed wherever a company hits its next commercial inflection point.
Which sectors does Rho explicitly avoid?
Rho does not publish an avoidance list, but its 300-company portfolio history concentrates on enterprise software, digital health, biotech, energy transition, and infrastructure-adjacent themes. The firm is notably absent from deep-military, hard-mining, and conventional fossil-fuel extraction in its public portfolio disclosures.
What is Rho's known posture on co-investments alongside external GPs?
Rho actively syndicates with outside venture and growth-equity investors, describing a philosophy of 'reciprocal relationships' built on trust and transparency with other investors around the table. The firm's preference is to stage capital alongside aligned partners rather than anchoring or leading every round unilaterally.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: